Does the media prefer INSP or KIDS?

In the previous week, Inspire Medical Systems had 2 more articles in the media than OrthoPediatrics. MarketBeat recorded 7 mentions for Inspire Medical Systems and 5 mentions for OrthoPediatrics. Inspire Medical Systems' average media sentiment score of 1.45 beat OrthoPediatrics' score of 0.35 indicating that Inspire Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspire Medical Systems 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OrthoPediatrics 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Is AXGN or KIDS more profitable?

AxoGen has a net margin of -13.36% compared to OrthoPediatrics' net margin of -15.72%. OrthoPediatrics' return on equity of -8.10% beat AxoGen's return on equity. Company Net Margins Return on Equity Return on Assets AxoGen -13.36% -8.90% -6.47% OrthoPediatrics -15.72% -8.10% -5.54%

Does the media prefer AXGN or KIDS?

In the previous week, AxoGen had 5 more articles in the media than OrthoPediatrics. MarketBeat recorded 10 mentions for AxoGen and 5 mentions for OrthoPediatrics. AxoGen's average media sentiment score of 0.54 beat OrthoPediatrics' score of 0.35 indicating that AxoGen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AxoGen 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive OrthoPediatrics 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor KIDS or ESTA?

In the previous week, OrthoPediatrics had 1 more articles in the media than Establishment Labs. MarketBeat recorded 5 mentions for OrthoPediatrics and 4 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.79 beat OrthoPediatrics' score of 0.35 indicating that Establishment Labs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OrthoPediatrics 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Establishment Labs 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer LMAT or KIDS?

In the previous week, OrthoPediatrics had 3 more articles in the media than LeMaitre Vascular. MarketBeat recorded 5 mentions for OrthoPediatrics and 2 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 0.45 beat OrthoPediatrics' score of 0.35 indicating that LeMaitre Vascular is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LeMaitre Vascular 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral OrthoPediatrics 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor KIDS or NVCR?

In the previous week, NovoCure had 1 more articles in the media than OrthoPediatrics. MarketBeat recorded 6 mentions for NovoCure and 5 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 0.35 beat NovoCure's score of 0.24 indicating that OrthoPediatrics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OrthoPediatrics 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral NovoCure 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

OrthoPediatrics (KIDS) Competitors

$21.88 -0.05 (-0.21%)

As of 11:00 AM Eastern

Compare

KIDS vs. INSP, AXGN, ESTA, LMAT, and NVCR

Should you buy OrthoPediatrics stock or one of its competitors? OrthoPediatrics's main competitors and comparable companies include Inspire Medical Systems (INSP), AxoGen (AXGN), Establishment Labs (ESTA), LeMaitre Vascular (LMAT), and NovoCure (NVCR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does OrthoPediatrics compare to Inspire Medical Systems?

Inspire Medical Systems (NYSE:INSP) and OrthoPediatrics (NASDAQ:KIDS) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation, media sentiment and dividends.

Inspire Medical Systems has a beta of 0.73, meaning that its stock price is 27% less volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market.

Inspire Medical Systems has a net margin of 15.03% compared to OrthoPediatrics' net margin of -15.72%. Inspire Medical Systems' return on equity of 8.64% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspire Medical Systems	15.03%	8.64%	7.45%
OrthoPediatrics	-15.72%	-8.10%	-5.54%

In the previous week, Inspire Medical Systems had 2 more articles in the media than OrthoPediatrics. MarketBeat recorded 7 mentions for Inspire Medical Systems and 5 mentions for OrthoPediatrics. Inspire Medical Systems' average media sentiment score of 1.45 beat OrthoPediatrics' score of 0.35 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inspire Medical Systems	6 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OrthoPediatrics	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 2.2% of Inspire Medical Systems shares are owned by company insiders. Comparatively, 32.5% of OrthoPediatrics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Inspire Medical Systems currently has a consensus target price of $67.88, suggesting a potential downside of 1.32%. OrthoPediatrics has a consensus target price of $26.50, suggesting a potential upside of 20.84%. Given OrthoPediatrics' stronger consensus rating and higher probable upside, analysts clearly believe OrthoPediatrics is more favorable than Inspire Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspire Medical Systems	4 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.05
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Inspire Medical Systems has higher revenue and earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspire Medical Systems	$911.98M	2.18	$145.42M	$4.62	14.89
OrthoPediatrics	$236.35M	2.42	-$39.65M	-$1.68	N/A

Summary

Inspire Medical Systems beats OrthoPediatrics on 10 of the 16 factors compared between the two stocks.

How does OrthoPediatrics compare to AxoGen?

AxoGen (NASDAQ:AXGN) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment.

80.3% of AxoGen shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 2.4% of AxoGen shares are owned by insiders. Comparatively, 32.5% of OrthoPediatrics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

AxoGen has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 0.99, suggesting that its stock price is 1% less volatile than the broader market.

AxoGen currently has a consensus target price of $51.73, suggesting a potential upside of 43.01%. OrthoPediatrics has a consensus target price of $26.50, suggesting a potential upside of 20.84%. Given AxoGen's stronger consensus rating and higher probable upside, research analysts clearly believe AxoGen is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AxoGen	1 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.80
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

AxoGen has a net margin of -13.36% compared to OrthoPediatrics' net margin of -15.72%. OrthoPediatrics' return on equity of -8.10% beat AxoGen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AxoGen	-13.36%	-8.90%	-6.47%
OrthoPediatrics	-15.72%	-8.10%	-5.54%

AxoGen has higher earnings, but lower revenue than OrthoPediatrics. AxoGen is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AxoGen	$225.21M	8.63	-$15.70M	-$0.68	N/A
OrthoPediatrics	$236.35M	2.42	-$39.65M	-$1.68	N/A

In the previous week, AxoGen had 5 more articles in the media than OrthoPediatrics. MarketBeat recorded 10 mentions for AxoGen and 5 mentions for OrthoPediatrics. AxoGen's average media sentiment score of 0.54 beat OrthoPediatrics' score of 0.35 indicating that AxoGen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AxoGen	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
OrthoPediatrics	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

AxoGen beats OrthoPediatrics on 12 of the 16 factors compared between the two stocks.

How does OrthoPediatrics compare to Establishment Labs?

OrthoPediatrics (NASDAQ:KIDS) and Establishment Labs (NASDAQ:ESTA) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment and earnings.

In the previous week, OrthoPediatrics had 1 more articles in the media than Establishment Labs. MarketBeat recorded 5 mentions for OrthoPediatrics and 4 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.79 beat OrthoPediatrics' score of 0.35 indicating that Establishment Labs is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Establishment Labs	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

OrthoPediatrics has a beta of 0.99, indicating that its share price is 1% less volatile than the broader market. Comparatively, Establishment Labs has a beta of 1.06, indicating that its share price is 6% more volatile than the broader market.

OrthoPediatrics has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	2.42	-$39.65M	-$1.68	N/A
Establishment Labs	$211.08M	8.25	-$51.06M	-$1.31	N/A

69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 72.9% of Establishment Labs shares are owned by institutional investors. 32.5% of OrthoPediatrics shares are owned by company insiders. Comparatively, 10.0% of Establishment Labs shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

OrthoPediatrics currently has a consensus price target of $26.50, indicating a potential upside of 20.84%. Establishment Labs has a consensus price target of $100.25, indicating a potential upside of 71.51%. Given Establishment Labs' stronger consensus rating and higher possible upside, analysts clearly believe Establishment Labs is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78

OrthoPediatrics has a net margin of -15.72% compared to Establishment Labs' net margin of -15.82%. OrthoPediatrics' return on equity of -8.10% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-15.72%	-8.10%	-5.54%
Establishment Labs	-15.82%	-196.69%	-10.73%

Summary

Establishment Labs beats OrthoPediatrics on 8 of the 15 factors compared between the two stocks.

How does OrthoPediatrics compare to LeMaitre Vascular?

LeMaitre Vascular (NASDAQ:LMAT) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.

LeMaitre Vascular has a beta of 0.48, indicating that its stock price is 52% less volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market.

84.6% of LeMaitre Vascular shares are held by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are held by institutional investors. 7.4% of LeMaitre Vascular shares are held by insiders. Comparatively, 32.5% of OrthoPediatrics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

LeMaitre Vascular has a net margin of 25.02% compared to OrthoPediatrics' net margin of -15.72%. LeMaitre Vascular's return on equity of 15.63% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular	25.02%	15.63%	10.06%
OrthoPediatrics	-15.72%	-8.10%	-5.54%

In the previous week, OrthoPediatrics had 3 more articles in the media than LeMaitre Vascular. MarketBeat recorded 5 mentions for OrthoPediatrics and 2 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 0.45 beat OrthoPediatrics' score of 0.35 indicating that LeMaitre Vascular is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LeMaitre Vascular	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
OrthoPediatrics	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

LeMaitre Vascular presently has a consensus price target of $110.60, suggesting a potential upside of 35.62%. OrthoPediatrics has a consensus price target of $26.50, suggesting a potential upside of 20.84%. Given LeMaitre Vascular's higher probable upside, equities analysts plainly believe LeMaitre Vascular is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LeMaitre Vascular	0 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.44
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

LeMaitre Vascular has higher revenue and earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular	$249.60M	7.47	$57.73M	$2.85	28.61
OrthoPediatrics	$236.35M	2.42	-$39.65M	-$1.68	N/A

Summary

LeMaitre Vascular beats OrthoPediatrics on 10 of the 15 factors compared between the two stocks.

How does OrthoPediatrics compare to NovoCure?

OrthoPediatrics (NASDAQ:KIDS) and NovoCure (NASDAQ:NVCR) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk and analyst recommendations.

OrthoPediatrics has higher earnings, but lower revenue than NovoCure. OrthoPediatrics is trading at a lower price-to-earnings ratio than NovoCure, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	2.42	-$39.65M	-$1.68	N/A
NovoCure	$655.35M	2.54	-$136.23M	-$1.30	N/A

OrthoPediatrics has a net margin of -15.72% compared to NovoCure's net margin of -21.25%. OrthoPediatrics' return on equity of -8.10% beat NovoCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-15.72%	-8.10%	-5.54%
NovoCure	-21.25%	-44.00%	-15.85%

OrthoPediatrics has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market. Comparatively, NovoCure has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market.

In the previous week, NovoCure had 1 more articles in the media than OrthoPediatrics. MarketBeat recorded 6 mentions for NovoCure and 5 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 0.35 beat NovoCure's score of 0.24 indicating that OrthoPediatrics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
NovoCure	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

OrthoPediatrics currently has a consensus price target of $26.50, suggesting a potential upside of 20.84%. NovoCure has a consensus price target of $21.20, suggesting a potential upside of 48.25%. Given NovoCure's higher probable upside, analysts clearly believe NovoCure is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
NovoCure	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14

69.1% of OrthoPediatrics shares are held by institutional investors. Comparatively, 84.6% of NovoCure shares are held by institutional investors. 32.5% of OrthoPediatrics shares are held by company insiders. Comparatively, 6.6% of NovoCure shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

OrthoPediatrics beats NovoCure on 8 of the 14 factors compared between the two stocks.

Get OrthoPediatrics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KIDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KIDS vs. The Competition

Export

Metric	OrthoPediatrics	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$571.03M	$5.52B	$7.25B	$13.04B
Dividend Yield	N/A	1.75%	2.52%	22.89%
P/E Ratio	-13.02	25.48	275.44	25.51
Price / Sales	2.42	66.54	562.05	79.58
Price / Cash	132.78	32.25	77.16	53.04
Price / Book	1.58	5.81	10.64	6.00
Net Income	-$39.65M	$146.14M	$3.49B	$380.50M
7 Day Performance	-2.65%	-1.66%	-3.21%	-3.35%
1 Month Performance	-2.04%	-4.35%	-7.65%	-6.23%
1 Year Performance	23.78%	0.80%	2.92%	-3.96%

OrthoPediatrics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KIDS OrthoPediatrics	2.7522 of 5 stars	$21.88 -0.2%	$26.50 +21.1%	+25.2%	$571.03M	$236.35M	N/A	602
INSP Inspire Medical Systems	2.7107 of 5 stars	$68.12 -3.7%	$67.29 -1.2%	-11.3%	$2.05B	$911.98M	14.74	1,333	Positive News Analyst Forecast
AXGN AxoGen	3.2274 of 5 stars	$36.31 -2.4%	$51.70 +42.4%	+132.0%	$2.00B	$225.21M	N/A	622	Analyst Forecast
ESTA Establishment Labs	2.8425 of 5 stars	$65.29 -1.8%	$100.25 +53.5%	+42.0%	$1.98B	$211.08M	N/A	1,004	Positive News
LMAT LeMaitre Vascular	4.3572 of 5 stars	$79.05 -2.4%	$110.60 +39.9%	-4.4%	$1.85B	$262.43M	27.74	655

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:KIDS) was last updated on 10/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OrthoPediatrics (KIDS) Competitors

KIDS vs. INSP, AXGN, ESTA, LMAT, and NVCR

How does OrthoPediatrics compare to Inspire Medical Systems?

Summary

How does OrthoPediatrics compare to AxoGen?

Summary

How does OrthoPediatrics compare to Establishment Labs?

Summary

How does OrthoPediatrics compare to LeMaitre Vascular?

Summary

How does OrthoPediatrics compare to NovoCure?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KIDS vs. The Competition

OrthoPediatrics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

OrthoPediatrics (KIDS) Competitors

KIDS vs. INSP, AXGN, ESTA, LMAT, and NVCR

How does OrthoPediatrics compare to Inspire Medical Systems?

Which has more risk & volatility, INSP or KIDS?

Is INSP or KIDS more profitable?

Does the media prefer INSP or KIDS?

Do institutionals and insiders hold more shares of INSP or KIDS?

Do analysts rate INSP or KIDS?

Which has better earnings & valuation, INSP or KIDS?

Summary

How does OrthoPediatrics compare to AxoGen?

Do insiders and institutionals hold more shares of AXGN or KIDS?

Which has more volatility and risk, AXGN or KIDS?

Do analysts prefer AXGN or KIDS?

Is AXGN or KIDS more profitable?

Which has stronger valuation & earnings, AXGN or KIDS?

Does the media prefer AXGN or KIDS?

Summary

How does OrthoPediatrics compare to Establishment Labs?

Does the media favor KIDS or ESTA?

Which has more volatility & risk, KIDS or ESTA?

Which has better valuation & earnings, KIDS or ESTA?

Do institutionals & insiders have more ownership in KIDS or ESTA?

Do analysts recommend KIDS or ESTA?

Is KIDS or ESTA more profitable?

Summary

How does OrthoPediatrics compare to LeMaitre Vascular?

Which has more risk and volatility, LMAT or KIDS?

Do insiders and institutionals have more ownership in LMAT or KIDS?

Is LMAT or KIDS more profitable?

Does the media prefer LMAT or KIDS?

Do analysts rate LMAT or KIDS?

Which has stronger earnings and valuation, LMAT or KIDS?

Summary

How does OrthoPediatrics compare to NovoCure?

Which has stronger valuation & earnings, KIDS or NVCR?

Is KIDS or NVCR more profitable?

Which has more risk & volatility, KIDS or NVCR?

Does the media favor KIDS or NVCR?

Do analysts rate KIDS or NVCR?

Do institutionals and insiders hold more shares of KIDS or NVCR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KIDS vs. The Competition

OrthoPediatrics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools